Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
RefloDx
AddedFeb 18, 2024
UpdatedJun 18, 2026
RefloDx

RefloDx

Angel

RefloDx offers non-invasive diagnostic tools and services for early reflux detection and imaging.

HQ
Clearfield, UT, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

RefloDx, founded with the mission to revolutionize diagnostic tools for reflux detection, focuses on providing non-invasive solutions for early identification and characterization of reflux events. Their flagship product, SondeFlux™, is a patented ultrasound-based device designed to detect Laryngopharyngeal Reflux (LPR) in a home setting. By offering standardized and objective evidence that correlates symptoms with LPR, RefloDx aims to improve patient outcomes and advance the diagnostic testing market.

Notable affiliated individuals and investors have yet to be publicly disclosed, but the company's innovative approach has already marked significant achievements. The development of SondeFlux™ represents a major advancement in non-invasive diagnostic technology, potentially reducing the need for more invasive procedures. RefloDx's impact lies in its potential to provide better diagnostics, thereby improving lives through early and accurate detection of reflux conditions.

RefloDx - Similar Companies

Dbmedx logo

Dbmedx

dbmedx.com

CeleFlux logo

CeleFlux

EndoSound logo

EndoSound

endosound.com

Reflow Medical logo

Reflow Medical

reflowmedical.com

Bright Uro logo

Bright Uro

brighturo.com

Respirix logo

Respirix

DxNow logo

DxNow

AmplifiDx logo

AmplifiDx

amplifidx.com

Cactus Medical logo

Cactus Medical

Vocxi Health logo

Vocxi Health

Sonogenix logo

Sonogenix

Sonix Medical Devices logo

Sonix Medical Devices

Lucid Diagnostics logo

Lucid Diagnostics

luciddx.com

Sonex Health logo

Sonex Health

sonexhealth.com

OtoNexus Medical Technologies logo

OtoNexus Medical Technologies

otonexus.com

RefloDx - Quick Facts

Who are RefloDx's competitors?

Companies similar to RefloDx include Dbmedx, CeleFlux, EndoSound and Reflow Medical.

When was RefloDx founded?

RefloDx was founded in 2015.

Where is RefloDx's headquarters located?

RefloDx's headquarters is located in Clearfield, UT, US.

When was RefloDx's last funding round?

RefloDx's most recent funding round was for $250k (USD) in May 2020.

How much has RefloDx raised to-date?

As of May 1, 2020, RefloDx has raised a total of $475k (USD).

How many employees does RefloDx have?

RefloDx has 6 employees as of Feb 4, 2024.

RefloDx - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • HealthTech
  • Ultrasound
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Diagnostic Tools
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
  • Medical Device
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities